AcelRx Pharmaceuticals
ACRX
#8069
Rank
$14.57 M
Marketcap
$0.86
Share price
7.50%
Change (1 day)
24.64%
Change (1 year)

P/E ratio for AcelRx Pharmaceuticals (ACRX)

P/E ratio as of March 2024 (TTM): -0.2783

According to AcelRx Pharmaceuticals 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.278317. At the end of 2022 the company had a P/E ratio of 0.4147.

P/E ratio history for AcelRx Pharmaceuticals from 2011 to 2023

PE ratio at the end of each year

Year P/E ratio Change
20220.4147-121.47%
2021-1.93-25.25%
2020-2.58-17.97%
2019-3.1511.79%
2018-2.8252.65%
2017-1.85-33.28%
2016-2.77-59.77%
2015-6.88-22.36%
2014-8.86-48.32%
2013-17.1507.42%
2012-2.8273.39%
2011-1.63

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-2.79 901.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.4417 58.72%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.